We are live on ! Find out more
FA

FCG Advisors Portfolio holdings

AUM $425M
1-Year Est. Return 12.09%
This Fund
S&P 500
This Quarter Est. Return
+5.06%
1 Year Est. Return
+12.09%
3 Year Est. Return
+19.73%
5 Year Est. Return
+52.93%
10 Year Est. Return
AUM
$247M
AUM Growth
+$24.5M
Cap. Flow
+$20.2M
Cap. Flow %
8.17%
Top 10 Hldgs %
60.99%
Holding
128
New
18
Increased
62
Reduced
30
Closed
7

Sector Composition

Rank Sector Weight
1 Healthcare 13.28%
2 Financials 4.61%
3 Technology 2.75%
4 Communication Services 1.64%
5 Energy 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DPLO
126
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
-34,000
Closed -$428K
AERG
127
DELISTED
APPLIED ENERGETICS, INC
AERG
-77,841
Closed -$2K

Similar funds

FCG Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, FCG Advisors held 128 positions worth $247M, up 11% from $223M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

FCG Advisors deployed $20.2M of net new capital in Q1 2017, opening 18 new positions and adding to 62 existing holdings. Its largest new stake was State Street SPDR Dow Jones Industrial Average ETF Trust: 6,934 shares worth $1.43M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Celgene Corp, an estimated $683K trimmed.

  • FCG Advisors's largest Q1 2017 buy was State Street SPDR Dow Jones Industrial Average ETF Trust: 6,934 shares worth $1.43M.
  • FCG Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $2.93M increase.
  • FCG Advisors's biggest Q1 2017 reduction was Celgene Corp, cutting an estimated $683K.
  • FCG Advisors fully exited DIPLOMAT PHARMACY, INC. in Q1 2017, selling an estimated $428K.
  • FCG Advisors's ten largest holdings make up 61% of its $247M portfolio in Q1 2017.
  • FCG Advisors opened 18 new positions and closed 7 in Q1 2017.
  • FCG Advisors's portfolio value rose 11% quarter-over-quarter to $247M.

Based on FCG Advisors's 13F filing for Q1 2017, filed 8 May 2017.